This sounds positive...
“ This third-party valuation report is the last piece of information required to enable us to set the price per share to meet the standards for the Nasdaq. ”
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.